Spoken Alpha
OmniAb, Inc.
OmniAb licenses antibody discovery technology platforms to pharmaceutical, biotechnology, and academic partners to accelerate identification of therapeutic antibody candidates.
OmniAb, Inc.
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-08-30.
Transcripts
We index calls for roughly 3,000 US-listed companies. If you'd like us to add OABIW, reply to your welcome email and we'll prioritize it.
History
Reported quarters with consensus, surprise, and 1-day reaction context.
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for OABIW.
$ curl https://api.spokenalpha.com/v1/companies/OABIWFAQ
Spoken Alpha indexes OABIW's earnings call transcripts at https://spokenalpha.com/companies/OABIW. Each call links to attributed speakers and parsed analyst Q&A. OmniAb, Inc.'s own investor relations page is at https://investors.omniab.com/overview/default.aspx.